Expert group meeting on paediatric heart failure

Icelandic is available via eTranslation, the European Commission's machine translation service.

Translate to Icelandic | Important information about machine translation

Date

Mánudagur, 29 nóvember 2010, All day

Staðsetning

European Medicines Agency, Amsterdam, the Netherlands

The meeting is identifying priorities for and the optimal design of studies on drug development in paediatric heart failure (HF) for the purpose of the evaluation of paediatric investigation plans. The main topics include new drug classes in the pipeline and priority list for HF drugs in children, types of paediatric HF to be studied, trial design issues and the establishment of a paediatric cardiology network.

Documents

Share this page